603658.SH
Autobio Diagnostics Co., Ltd.
SSE · Healthcare · Medical - Diagnostics & Research · CN
CNY 37.74
−1.18%Year over year
Reported trailing growth
- Revenue
- -3.5%
- EBITDA
- —
- EBIT
- -0.7%
- EPS
- -8.4%
- Free cash flow
- +29.0%
- Operating cash flow
- +15.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -1.6%
- EBITDA
- -0.8%
- EBIT
- -2.1%
- Net income
- -2.9%
- EPS
- -2.2%
- Free cash flow
- +5.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026